Trial intelligence / Profile preview

Calcipotriol + betamethasone dipropionate gel in scalp psoriasis

2004-002015-86Phase 3Completed

Sponsor
LEO Pharma
Start
Oct 2004
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of calcipotriol and betamethasone dipropionate in psoriasis (4 arms), sponsored by LEO Pharma. Primary endpoint: Controlled disease at end of treatment. Started Oct 2004; status: completed.

02

Drugs

calcipotriolbetamethasone dipropionate
03

Conditions

psoriasis

Beyond the preview

Go deeper on 2004-002015-86.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-002015-86.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call